RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 55 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $961,727 | +39.5% | 41,951 | +0.4% | 0.01% | +33.3% |
| Q2 2023 | $689,167 | +3.3% | 41,793 | +11.8% | 0.01% | 0.0% |
| Q1 2023 | $667,002 | -40.0% | 37,388 | -2.1% | 0.01% | -40.0% |
| Q4 2022 | $1,112,326 | -25.1% | 38,198 | -44.5% | 0.01% | -16.7% |
| Q3 2019 | $1,486,000 | -6.3% | 68,850 | -4.5% | 0.01% | 0.0% |
| Q2 2019 | $1,586,000 | -30.4% | 72,070 | -13.3% | 0.01% | -25.0% |
| Q1 2019 | $2,278,000 | +6.5% | 83,115 | +4.5% | 0.02% | -5.9% |
| Q4 2018 | $2,138,000 | +21.2% | 79,521 | +31.5% | 0.02% | +41.7% |
| Q3 2018 | $1,764,000 | +41.2% | 60,476 | +51.4% | 0.01% | +50.0% |
| Q2 2018 | $1,249,000 | +71.6% | 39,952 | +9.2% | 0.01% | +33.3% |
| Q1 2018 | $728,000 | – | 36,593 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |